Aptorum Group Limited

NasdaqCM:APM Stock Report

Market Cap: US$6.5m

Aptorum Group Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Ian Huen

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure2.5yrs
CEO ownership25.3%
Management average tenureno data
Board average tenure5.5yrs

Recent management updates

Recent updates

Seeking Alpha • Oct 03

Aptorum Group GAAP EPS of -$0.05

Aptorum Group press release (NASDAQ:APM): 1H GAAP EPS of -$0.05. As of June 30, 2022, cash and restricted cash totalled approximately $7.2 million and total equity was approximately $15.6 million. Aptorum Group expects that its existing cash and restricted cash together with undrawn line of credit facility from related parties, will enable it to fund its operating and capital expenditure requirements for at least the next 12 months.
Analysis Article • Jul 14

Is Aptorum Group (NASDAQ:APM) In A Good Position To Deliver On Growth Plans?

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
Seeking Alpha • Feb 11

Aptorum Group: Advancing Oncology, Autoimmune & Infectious Disease Therapies

Aptorum Group is advancing therapeutic programs to serve unmet needs in orphan oncology diseases, infectious diseases, metabolic diseases, women's health and other areas. The company completed Phase 1 clinical trials for its two lead candidates ALS-4 and SACT-1. The company also launched its oncology and autoimmune discovery and development platform focusing initially on NSCLC, Lupus, RA, IBD, etc.
Analysis Article • Apr 26

We Think Shareholders Should Be Aware Of Some Factors Beyond Aptorum Group's (NASDAQ:APM) Profit

Despite posting strong earnings, Aptorum Group Limited's ( NASDAQ:APM ) stock didn't move much over the last week. We...
Analysis Article • Jan 16

Do Institutions Own Aptorum Group Limited (NASDAQ:APM) Shares?

The big shareholder groups in Aptorum Group Limited ( NASDAQ:APM ) have power over the company. Institutions will often...

CEO Compensation Analysis

How has Ian Huen's remuneration changed compared to Aptorum Group's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2025n/an/a

-US$1m

Sep 30 2025n/an/a

-US$2m

Jun 30 2025n/an/a

-US$2m

Mar 31 2025n/an/a

-US$3m

Dec 31 2024n/an/a

-US$4m

Sep 30 2024n/an/a

-US$2m

Jun 30 2024n/an/a

US$19k

Mar 31 2024n/an/a

-US$1m

Dec 31 2023US$397kn/a

-US$3m

Sep 30 2023n/an/a

-US$8m

Jun 30 2023n/an/a

-US$13m

Mar 31 2023n/an/a

-US$12m

Dec 31 2022US$1mUS$134k

-US$10m

Sep 30 2022n/an/a

-US$10m

Jun 30 2022n/an/a

-US$11m

Mar 31 2022n/an/a

-US$18m

Dec 31 2021US$987kUS$288k

-US$25m

Sep 30 2021n/an/a

-US$14m

Jun 30 2021n/an/a

-US$4m

Mar 31 2021n/an/a

US$1m

Dec 31 2020US$627kUS$288k

US$6m

Sep 30 2020n/an/a

-US$5m

Jun 30 2020n/an/a

-US$16m

Mar 31 2020n/an/a

-US$17m

Dec 31 2019US$592kUS$288k

-US$19m

Compensation vs Market: Insufficient data to establish whether Ian's total compensation is reasonable compared to companies of similar size in the US market.

Compensation vs Earnings: Ian's compensation has been consistent with company performance over the past year.

CEO

Ian Huen (45 yo)

2.5yrs
Tenure

Mr. Chung Yuen Huen, also known as Ian, is Chief Executive Officer and Executive Director of Aptorum Group Limited from November 27, 2023. He is a Founder of Aptorum Group Limited and serves as its Executi...

Board Members

NamePositionTenureCompensationOwnership
Chung Yuen Huen
Founder2.5yrsno data25.3%
$ 1.6m
William Weiss
Member of Scientific Advisory Board5.5yrsno datano data
Kwei-Hang Chan
Member of Scientific Advisory Board7.1yrsUS$120.00kno data
Douglas W. Arner
Independent Non-Executive Director8.1yrsno datano data
Justin Wu
Independent Non-Executive Director8.6yrsno datano data
Lawrence Baum
Member of Scientific Advisory Board5.5yrsno datano data
Francis Szele
Member of Scientific Advisory Board5.5yrsno datano data
5.5yrs
Average Tenure
54.5yo
Average Age

Experienced Board: APM's board of directors are considered experienced (5.5 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/14 22:44
End of Day Share Price 2026/05/14 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Aptorum Group Limited is covered by 7 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
James MolloyAlliance Global Partners
null nullArgus Research Company
Yue-Kwong LuiChina Renaissance Securities